RAIsonance Group

Raisonance is headquartered in the Denver Tech Center in Colorado, dedicated to Artificial Intelligence/Machine Learning-based healthcare solutions, focused on using artificial intelligence to detect patterns in the sound of human coughs. RAIsonance companies operate a suite of respiratory solutions to detect and screen for specific respiratory illnesses and to monitor respiratory wellness. Our products include: • AUDIBLEHEALTH AI is a Clinical Decision Support Software solution designed to screen for and detect respiratory diseases in the intricate patterns found in the sound of a human cough. Users cough for approximately 10 seconds into the AudibleHealth app, and a result is returned in around 30 seconds. At present the solution supports detection for Tuberculosis, COVID-19, Pneumonia, and Smoker status with another 15+ solutions in development. Future indications on the product roadmap include Measles, RSV, Influenza, Pertussis, Lung Cancer, and many more. • FCV SENTINEL is a threat-agnostic early warning system, based on RAIsonance’s proprietary cough analysis technology. This tool is designed to detect subtle changes that may be the result of exposure to a pathogen, chemical agent, or environmental toxin experienced by the user. For businesses and organizations, aggregate data is presented on interactive dashboards in near real time, and can be customized to track readiness by group, location, region, etc. • MYADVOCATE is designed to support those with chronic respiratory conditions such as COPD and asthma. The solution creates an in-depth, completely unique profile for each user, and then monitors even very small changes that indicate a problem with their respiratory health. MyAdvocate provides a fast, biometric, early-warning signal of a potential respiratory health issue. Connect with the RAIsonance Group of companies at www.raisonance.ai and at FCVWellness.com or on Twitter @RAIsonanceGroup.